Latest Remuneration News

Qualitas Limited posted a 25% rise in net profit for FY26, driven by a 36% increase in fee earning funds under management and a strategic UK acquisition that expands its European presence.

BSA Limited’s FY26 results reveal a dramatic 89% plunge in revenue following the loss of the nbn contract, yet profit after tax rose 14% to $4.27 million as the company restructured and secured a key Foxtel contract extension.

MaxiPARTS Limited lifted net profit by 13% to $8.7 million for FY26, boosted by organic growth, a new Kalgoorlie site, and disciplined cost management, while declaring a 5.46 cent fully franked final dividend.

Wrkr Ltd surged revenue 52.6% to $16.2 million in FY2026 but saw net losses widen to $8.4 million as it transitioned to live Payday Super execution and integrated PaidRight. The company raised $12 million post-year-end to fuel onboarding and product growth.

Cleo Diagnostics (ASX:COV) posted a 48% jump in annual loss to $5.9 million amid key progress in its ovarian cancer diagnostic test, including completion of a pivotal US trial and preparations for FDA 510(k) submission.

At its 2026 Annual Meeting, General Capital shareholders voted decisively against re-electing Managing Director Brent King, while approving a near 10% increase in the total director remuneration pool.

Servcorp Limited delivered a record FY26 with a 24% rise in underlying NPBIT to $87 million, boosted dividends by 14%, and outlined a cautious yet optimistic FY27 growth strategy.

Eureka Group Holdings (ASX: EGH) posted a 29% rise in underlying EBITDA for FY26, driven by rapid growth in its all-age rental segment and disciplined capital deployment, while statutory profit dipped due to one-off costs and tax adjustments.

Codan Limited posted a robust FY26 with revenue up 30% to $875 million and net profit soaring 69% to $175 million, underpinned by strong demand in communications and metal detection segments. The company declared a fully franked final dividend of 29 cents, lifting the full-year payout by 70%.

Medical Developments International (ASX:MVP) reported a 9% revenue increase to $42.6 million and a 566% jump in net profit to $0.6 million for FY26, driven by robust growth in its Pain Management segment and expanded paediatric approvals in Europe.

Zip Co Limited (ASX: ZIP) reported a 46% rise in net profit to $116.4 million for FY26, driven by strong US and ANZ market growth and record cash earnings of $268.9 million. The company also announced an orderly wind down of its New Zealand operations to focus on its core markets.

Cuscal Limited reported a 49% jump in statutory profit after tax to $42.7 million for FY26, driven by strategic acquisitions of Indue and Paymark that expanded its Australian and New Zealand footprint. The company declared a fully franked 7-cent final dividend and expects mid-twenties percentage growth in underlying profit and transaction volumes for FY27.